BIOGRAPHY

Prior to joining Retrophin, Dr. Valeur-Jensen served as Of Counsel at Seed Intellectual Property Law Group PLLC in the Biotechnology, Pharmaceuticals and Chemistry Group. Previously, she was Executive Vice President and General Counsel of Neurocrine Biosciences, Inc. Earlier, she was Associate General Counsel Business Law Group of Amgen Inc., where she was responsible for licensing and corporate partnering, mergers and acquisitions, clinical development, sales and marketing, regulatory affairs, and real estate. Prior to joining Amgen, she was an associate at Davis, Polk & Wardwell. Dr. Valeur-Jensen received her J.D. from Stanford University School of Law. In addition, she was a Post-Doctoral Fellow at Harvard Medical School in the Department of Genetics, as well as at Massachusetts General Hospital in the Department of Molecular Biology. She received a Ph.D. in Biochemistry and Molecular Biology from Syracuse University and a B.A. in Biology from Skidmore College.